Gold nanoparticles improve effectiveness of medicines
Gold is an excellent candidate for nanomedicine because it is well tolerated by the body and is easily malleable
Keystone
Researchers at the University of Geneva (UNIGE), in collaboration with other institutions, have successfully highlighted the impact of gold nanoparticles on B lymphocytes.
This content was published on
2 minutes
Keystone-SDA/ts
These results, published in the journal ACS NanoExternal link, should pave the way for more effective vaccines and therapies.
B-cells are a crucial part of the immune system and thus an attractive target for vaccine development. However, to fulfil their goal, vaccines must reach B cells quickly without being destroyed en route, UNIGE said in a statement on Friday.
This is where the use of nanoparticles can be interesting.
“Nanoparticles can form a protective vehicle for vaccines – or other drugs – to specifically deliver them where they can be most effective, while sparing other cells,” explained Carole Bourquin, professor at UNIGE’s Faculties of Medicine and ScienceExternal link, who co-led the study.
“This targeting also allows the use of a lower dose of immunostimulant while maintaining an effective immune response. It increases its efficacy while reducing side-effects, provided that the nanoparticles are harmless to all immune cells.”
Golden opportunity
Gold is an excellent candidate for nanomedicine because of its particular physico-chemical properties, the authors wrote. Well tolerated by the body and easily malleable, this metal has, for instance, the particularity of absorbing light and then releasing heat, a property that can be exploited in oncology.
“Gold nanoparticles can be used to target tumours. When exposed to a light source, the nanoparticles release heat and destroy neighbouring cancer cells. We could also attach a drug to the surface of the nanoparticles to be delivered to a specific location,” said UNIGE researcher Sandra Hočevar.
The gold nanoparticles developed by the team of researchers could make it possible to deliver existing drugs directly to B lymphocytes to reduce the necessary dosage and potential side effects. In fact, studies in patients are already being carried out for the treatment of brain tumours, the researchers said.
More
More
Demographics
Cancer in the crosshairs
This content was published on
Switzerland has joined an unprecedented scientific collaboration to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
Boats sail to Solothurn to celebrate 700 years of Le Landeron
This content was published on
The challenge of crossing Lake Biel from Le Landeron to Solothurn without a motor was taken up by 16 amateur crews on Saturday. The competition is part of Le Landeron's 700th anniversary celebrations.
Swiss cantonal ministers keep low profile on social media
This content was published on
A small base of followers and neutral posts: these are the conclusions that emerge from a study published by UNIL researchers into the use of social networks by councillors of state.
Swiss rents forecast to rise up to 5% annually, housing chief warns
This content was published on
Rents on the Swiss market are set to rise by between 3% and 5% a year over the next few years, warned Martin Tschirren, Director of the Federal Housing Office (FHO), on Sunday. "Demand for housing remains higher than supply".
This content was published on
The Council of the Swiss Abroad, meeting today in Bern, passed a resolution in favour of the new Electronic Identity Act (Id-e), which will be put to the vote on 28 September.
One person consumes 4.8 megawatt hours of electricity
This content was published on
On average, the Swiss consume 4.8 megawatt hours of electricity per year. According to Velobiz.de, this is roughly equivalent to the amount generated by all 176 cyclists in the Tour de France during the entire race.
Outgoing ICRC chief in Ukraine defends neutrality amid war
This content was published on
Swiss national Jürg Eglin, outgoing head of the International Committee of the Red Cross in Ukraine, reflects on his tenure.
Green party leader criticises government’s neo-liberal policy
This content was published on
The Green Party delegates' meeting opened on Saturday morning in Vicques (JU) with a speech by party president Lisa Mazzone. Mazzone took particular aim at the Federal Council's policy towards the United States.
Working on Sundays is detrimental to well-being, says Swiss study
This content was published on
A study by the University of Bern shows that working on Sundays is detrimental to well-being and particularly affects women.
Safra Sarasin private bank and former asset manager sentenced
This content was published on
The Office of the Attorney General of Switzerland has fined private bank J. Safra Sarasin CHF3.5 million for aggravated money laundering. A former bank employee received a six-month suspended prison sentence.
JPMorgan to pay CHF270 million to settle 1MDB claims
This content was published on
JPMorgan Chase has agreed to pay CHF270 million to the Malaysian government to settle all issues related to its role in the 1MDB financial scandal.
Study finds nanoparticles in over one-quarter of foodstuffs
This content was published on
Nanoparticles were found in over one-quarter of the foodstuffs tested in a pilot study carried out in French-speaking Switzerland.
This content was published on
Lukas Novotny and his ETHZ collaborators at the Institute for Photonics manipulated a minuscule piece of glass only a hundred nanometres in size – a thousand times smaller than a hair – in such a way as to make it turn around its own axis more than a billion times a second. The results of…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.